CalciMedica
CALC
12 hedge funds and large institutions have $1.49M invested in CalciMedica in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
5% less capital invested
Capital invested by funds: $1.56M → $1.49M (-$74.3K)
1.33% less ownership
Funds ownership: 10.46% → 9.12% (-1.3%)
8% less funds holding
Funds holding: 13 → 12 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$164K |
| 2 |
MPM
Meritage Portfolio Management
Overland Park,
Kansas
|
+$104K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.55K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.38K |
| 5 |
Morgan Stanley
New York
|
+$451 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$432K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.22K |
CALC Hedge Fund Activity: Q4 2023 in Review
12 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2023, worth a combined $1.49M — down 4.8% from $1.56M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CALC and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 6 added.
The largest buyer was BML Capital Management, adding an estimated $164K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $432K sold.
- 12 institutional investors held CalciMedica (CALC) as of Q4 2023, down from 13 in Q3 2023.
- Funds reported $1.49M of CalciMedica stock for Q4 2023, down 4.8% quarter-over-quarter.
- 0 funds opened new CalciMedica positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest CalciMedica buyer in Q4 2023 was BML Capital Management, an estimated $164K added.
- The largest CalciMedica seller in Q4 2023 was Hudson Bay Capital Management, an estimated $432K sold.
Based on aggregated 13F filings for Q4 2023.